Claims for Patent: 9,222,104

Summary for Patent: 9,222,104

Title:	Method for creating broad-spectrum resistance to fungi in transgenic plants
Abstract:	The present invention relates to the creation of broad-spectrum resistance in transgenic plants by inserting inhibitory nucleic acid sequences inhibiting the expression of fungal genes. The nucleic acid sequences of genes which are crucial to development, growth and profilation of fungi, i.e. sequences of genes with an essential function in fungi, are often conserved and/or have a high sequence identity. Regions having a particularly high sequence identity between various fungi are used in order to produce inhibitory gene constructs, e.g. on basis of antisense, siRNA, shRNA, ribozyme technology and other technologies imparting the inhibition of the expression and activation of genes. Since said methods base on the sequence-specific hybridization of the inhibitory RNA molecules with respective target sequences in certain fungal genes, the expression of all corresponding genes from various fungi is thus inhibited as well. Due to the high sequence identity of such conserved gene sections, transgenic plants are thus produced, which have broad-spectrum resistance to various fungi.
Inventor(s):	Schweizer; Patrick (Ballenstedt, DE), Hensel; Goetz (Koethen, DE), Gay; Alexandra (Odenthal, DE), Kumlehn; Jochen (Postdam, DE)
Assignee:	The Leibniz Institute of Plant Genetics and Crop Plant Research (Gatersleben, DE)
Application Number:	12/922,454
Patent Claims:	1. A method for creating broad-spectrum resistance to fungi in a transgenic plant, characterized in that a recombinant nucleic acid molecule comprising at least one nucleic acid sequence is introduced into the plant, wherein the at least one nucleic acid sequence is identical and/or complementary to the nucleic acid sequence according to SEQ ID NO 12, and/or a part thereof comprising at least 100 nucleotides, or has a sequence identity of at least 98% to the nucleic acid sequence according to SEQ ID NO: 12, and is transcribed in the plant, so that in case of an infection of the plant with a fungus, the nucleic acid sequence, or part thereof, interacts with one or more corresponding and/or complementary nucleic acids of the fungus, such that the expression of the fungal nucleic acid sequence is reduced by at least 80%, thereby creating broad-spectrum resistance to fungi in the transgenic plant, wherein the nucleic acid sequence comprises at least 100 nucleotides and wherein the nucleic acid sequence according to SED ID NO: 12 is the conserved region within the mitochondrial ADP/ATP translocator consensus sequence. 2. The method according to claim 1, wherein the recombinant nucleic acid molecule comprises: (a) a promoter functional in plants, and (b) operatively linked thereto the at least one nucleic acid sequence. 3. The method according to claim 1, wherein the recombinant nucleic acid molecule comprises: (a) a promoter functional in plants, (b) operatively linked thereto the at least one nucleic acid sequence, (c) an intron comprising a splice donor sequence and a splice acceptor sequence, (d) the nucleic acid sequence being reverse-complementary to the nucleic acid sequence mentioned in (b), and (e) a termination sequence. 4. The method according to claim 1, wherein the recombinant nucleic acid molecule comprises: (a) a promoter functional in plants, (b) operatively linked thereto the at least one nucleic acid sequence, wherein said sequence has reverse-complementary regions, and (c) a termination sequence. 5. The method according to claim 1, wherein the recombinant nucleic acid molecule comprises: (a) a promoter functional in plants, (b) operatively linked thereto the at least one nucleic acid sequence, (c) a second nucleic acid sequence encoding a ribonuclease P, and (d) a termination sequence. 6. The method according to claim 2, wherein the promoter is a constitutive promoter, an inducible promoter or a tissue-specific promoter. 7. The method according to claim 1, wherein the transgenic plant is a dicotyledonous or monocotyledonous plant. 8. The method according to claim 7, wherein the plant is a cereal plant. 9. The method according to claim 1, wherein the broad-spectrum resistance is against pathogenic fungi. 10. The method according to claim 3, wherein the promoter is a constitutive promoter, an inducible promoter or a tissue-specific promoter. 11. The method according to claim 4, wherein the promoter is a constitutive promoter, an inducible promoter or a tissue-specific promoter. 12. The method according to claim 5, wherein the promoter is a constitutive promoter, an inducible promoter or a tissue-specific promoter. 13. The method of claim 8 wherein the cereal plant is wheat or barley.

Details for Patent 9,222,104

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2028-03-13
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2028-03-13
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2028-03-13